Eurofins Scientific Sa (ERFSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 304,080 | 342,301 | 282,694 | N/A | N/A |
| Depreciation Amortization | 443,408 | 264,245 | 198,614 | N/A | N/A |
| Accounts receivable | -152,544 | -187,994 | -204,819 | N/A | N/A |
| Accounts payable and accrued liabilities | 41,216 | 84,025 | 81,089 | N/A | N/A |
| Other Working Capital | -71,792 | -24,570 | -12,139 | N/A | N/A |
| Other Operating Activity | 194,880 | 164,333 | 112,472 | 0 | 0 |
| Operating Cash Flow | $759,248 | $642,340 | $457,909 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 53,312 | 63,626 | -3,969 | N/A | N/A |
| PPE Investments | -420,448 | -376,932 | -189,387 | N/A | N/A |
| Net Acquisitions | -191,520 | -1,481,276 | -1,734,289 | N/A | N/A |
| Purchase Sale Intangibles | -49,616 | -49,843 | -50,965 | N/A | N/A |
| Other Investing Activity | -46,368 | -44,763 | -47,086 | 0 | 0 |
| Investing Cash Flow | $-605,024 | $-1,839,344 | $-1,974,731 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 330,176 | 1,404,636 | 994,361 | N/A | N/A |
| Debt Repayment | -498,400 | -433,413 | -156,981 | N/A | N/A |
| Common Stock Issued | 359,520 | 23,668 | 361,751 | N/A | N/A |
| Dividend Paid | -57,568 | -50,364 | -39,461 | N/A | N/A |
| Other Financing Activity | -516,992 | -128,381 | 358,652 | 0 | 0 |
| Financing Cash Flow | $-383,264 | $816,147 | $1,518,323 | $N/A | $N/A |
| Exchange Rate Effect | 4,592 | 1,730 | -12,398 | N/A | N/A |
| Beginning Cash Position | 554,400 | 963,727 | 933,251 | N/A | N/A |
| End Cash Position | 329,840 | 584,599 | 922,354 | N/A | N/A |
| Net Cash Flow | $-224,560 | $-379,128 | $-10,897 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 759,248 | 642,340 | 457,909 | N/A | N/A |
| Capital Expenditure | -426,496 | -380,571 | -226,789 | N/A | N/A |
| Free Cash Flow | 332,752 | 261,769 | 231,120 | 0 | 0 |